股本结构
单位：万股
| 公告日期 | 2024-11-14 | 2024-10-29 | 2024-10-23 | 2024-09-16 | 2024-08-12 | 2024-08-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 452.27 | 442.31 | 367.77 | 3677.75 | 3646.91 | 3594.32 |
| 普通股本 | 452.27 | 442.31 | 367.77 | 3677.75 | 3646.91 | 3594.32 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-11-06 | 2024-10-29 | 2024-10-18 | 2024-09-10 | 2024-08-06 | 2024-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-11-14 | 452.27 | 未披露 | 定期报告 | 2024-11-06 |
| 2024-10-29 | 442.31 | 未披露 |
更多>>
Common stock offered 745,342 shares by the company
|
2024-10-29 |
| 2024-10-23 | 367.77 | 未披露 |
更多>>
a reverse stock split of the Company’s common stock, par value $0.001 per share, at a ratio of 10:1
|
2024-10-18 |
| 2024-09-16 | 3677.75 | 未披露 | 定期报告 | 2024-09-10 |
| 2024-08-12 | 3646.91 | 未披露 | 定期报告 | 2024-08-06 |
| 2024-08-12 | 3594.32 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock, net
|
2024-06-30 |
| 2024-07-01 | 3594.33 | 未披露 | 定期报告 | 2024-06-27 |
| 2024-04-08 | 3588.38 | 未披露 | 定期报告 | 2024-04-03 |
| 2024-05-15 | 3042.93 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
|
2024-03-31 |
| 2024-04-01 | 3031.34 | 未披露 | 定期报告 | 2024-03-20 |
| 2024-04-01 | 2933.64 | 未披露 | 定期报告 | 2024-03-01 |
| 2024-04-01 | 2783.76 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock upon conversion of debt, net
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
|
2023-12-31 |
| 2023-12-22 | 2720.93 | 未披露 | 定期报告 | 2023-12-20 |
| 2023-11-13 | 2370.37 | 未披露 | 定期报告 | 2023-11-06 |
| 2023-11-13 | 2341.10 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon conversion of debt, net
|
2023-09-30 |
| 2023-08-14 | 1388.38 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-08-14 | 1342.09 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
|
2023-06-30 |
| 2023-06-13 | 1336.85 | 未披露 |
更多>>
Common Stock offered by the company 1,509,434 shares
|
2023-06-14 |
| 2023-04-27 | 1185.91 | 未披露 | 定期报告 | 2023-04-20 |
| 2023-05-15 | 1185.90 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
|
2023-03-31 |
| 2023-03-30 | 1182.85 | 未披露 | 定期报告 | 2023-03-20 |
| 2023-04-27 | 1178.33 | 未披露 | 定期报告 | 2023-03-01 |
| 2023-01-27 | 924.96 | 未披露 | 定期报告 | 2023-01-12 |
| 2022-12-30 | 892.68 | 未披露 |
更多>>
Following the Special Meeting of Stockholders of Biora Therapeutics, Inc. (the “Company”) held on December 19, 2022, the Company’s Board of Directors approved a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 25:1 (the “Reverse Stock Split Ratio”) and a reduction in the total number of authorized shares of Common Stock from 350,000,000 shares to 164,000,000 shares (the “Authorized Shares Reduction”), each with an effective time of 12:01 a.m. Eastern Time on January 3, 2023 (the “Effective Time”).
|
2023-01-03 |
| 2022-11-29 | 22317.06 | 22.32 | 定期报告 | 2022-11-23 |
| 2022-11-09 | 22160.36 | 未披露 |
更多>>
Common stock offered 32,506,250 shares by the company
|
2022-11-09 |
| 2022-11-14 | 19041.28 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-14 | 18909.73 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock unit awards
|
2022-09-30 |
| 2022-08-15 | 18662.36 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-15 | 18629.00 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock, net
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock unit awards
|
2022-06-30 |
| 2022-04-28 | 18419.89 | 未披露 | 定期报告 | 2022-04-21 |
| 2022-05-10 | 18419.79 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
|
2022-03-31 |
| 2022-03-28 | 18412.58 | 未披露 | 定期报告 | 2022-03-15 |
| 2022-04-28 | 18235.12 | 未披露 | 定期报告 | 2022-02-01 |
| 2022-03-28 | 18187.27 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock, net
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock units
Exercise of common stock warrants
Issuance of common stock upon conversion of debt, net
Issuance of common stock upon conversion of interest, net
|
2021-12-31 |
| 2021-11-10 | 16374.96 | 未披露 | 定期报告 | 2021-11-04 |
| 2021-10-06 | 14403.90 | 未披露 |
更多>>
1.Common stock offered by this prospectus supplement 13,333,334 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 78,347,654 shares of common stock outstanding as of June 30, 2021.
|
2021-10-06 |
| 2021-11-10 | 11956.77 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of common stock upon exercise of warrants
Issuance of common stock upon conversion of debt, net
|
2021-09-30 |
| 2021-08-24 | 11834.77 | 未披露 |
更多>>
1.Common stock offered by company 40,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 78,347,654 shares of common stock outstanding as of June 30, 2021.
|
2021-08-24 |
| 2021-08-12 | 7940.63 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-12 | 7835.78 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of common stock upon conversion of debt, net
Issuance of common stock upon conversion of interest, net
|
2021-06-30 |
| 2021-06-18 | 7773.02 | 未披露 | 定期报告 | 2021-06-14 |
| 2021-06-01 | 6047.41 | 未披露 | 定期报告 | 2021-05-05 |
| 2021-05-13 | 6047.46 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-15 | 6034.22 | 未披露 | 定期报告 | 2021-04-08 |
| 2021-05-13 | 6034.04 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock upon vesting of restricted stock unit awards
|
2021-03-31 |
| 2021-03-18 | 6025.18 | 未披露 | 定期报告 | 2021-02-28 |
| 2021-03-18 | 5577.23 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock upon exercise of options
Issuance of common stock upon initial public offering, net
Issuance of common stock upon secondary public offering, net
Automatic conversion of preferred stock
Issuance of common stock upon conversion of debt
Issuance of common stock upon conversion of debt
|
2020-12-31 |
| 2020-12-14 | 5579.27 | 未披露 | 定期报告 | 2020-12-14 |
| 2020-12-07 | 5462.15 | 未披露 |
更多>>
1.Common stock offered by the company 7,645,259 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 46,976,277 shares of common stock outstanding as of September 30, 2020.
|
2020-12-07 |
| 2020-12-03 | 4700.07 | 未披露 | 定期报告 | 2020-12-02 |
| 2020-12-01 | 4684.92 | 未披露 | 定期报告 | 2020-11-01 |
| 2020-11-09 | 4697.63 | 未披露 |
更多>>
from June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of options
|
2020-09-30 |
| 2020-08-14 | 4654.80 | 未披露 |
更多>>
from March 31, 2020 to June 30, 2020
Issuance of common stock upon exercise of options
Issuance of common stock upon initial public offering, net
Automatic conversion of preferred stock
Issuance of common stock upon conversion of debt
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of Series B Preferred Stock, net
|
2020-06-30 |
| 2020-06-22 | 4516.38 | 未披露 |
更多>>
1.Common stock offered by us 6,666,667 shares.
|
2020-06-19 |
Common stock offered 745,342 shares by the company
a reverse stock split of the Company’s common stock, par value $0.001 per share, at a ratio of 10:1
From March 31, 2024 to June 30, 2024
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock, net
From December 31, 2023 to March 31, 2024
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
From December 31, 2022 to December 31, 2023
Issuance of common stock upon conversion of debt, net
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
From June 30, 2023 to September 30, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon conversion of debt, net
From March 31, 2023 to June 30, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
Common Stock offered by the company 1,509,434 shares
From December 31, 2022 to March 31, 2023
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
Following the Special Meeting of Stockholders of Biora Therapeutics, Inc. (the “Company”) held on December 19, 2022, the Company’s Board of Directors approved a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a ratio of 25:1 (the “Reverse Stock Split Ratio”) and a reduction in the total number of authorized shares of Common Stock from 350,000,000 shares to 164,000,000 shares (the “Authorized Shares Reduction”), each with an effective time of 12:01 a.m. Eastern Time on January 3, 2023 (the “Effective Time”).
Common stock offered 32,506,250 shares by the company
From June 30, 2022 to September 30, 2022
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock unit awards
From March 31, 2022 to June 30, 2022
Issuance of common stock, net
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock unit awards
From December 31, 2021 to March 31, 2022
Issuance of common stock, net
Issuance of common stock upon vesting of restricted stock units
From December 31, 2020 to December 31, 2021
Issuance of common stock, net
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock units
Exercise of common stock warrants
Issuance of common stock upon conversion of debt, net
Issuance of common stock upon conversion of interest, net
1.Common stock offered by this prospectus supplement 13,333,334 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 78,347,654 shares of common stock outstanding as of June 30, 2021.
From June 30, 2021 to September 30, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of common stock upon exercise of warrants
Issuance of common stock upon conversion of debt, net
1.Common stock offered by company 40,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 78,347,654 shares of common stock outstanding as of June 30, 2021.
From March 31, 2021 to June 30, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of common stock upon conversion of debt, net
Issuance of common stock upon conversion of interest, net
From December 31, 2020 To March 31, 2021
Issuance of common stock, net
Issuance of common stock upon exercise of options
Issuance of common stock upon vesting of restricted stock unit awards
From December 31, 2019 to December 31, 2020
Issuance of common stock upon exercise of options
Issuance of common stock upon initial public offering, net
Issuance of common stock upon secondary public offering, net
Automatic conversion of preferred stock
Issuance of common stock upon conversion of debt
Issuance of common stock upon conversion of debt
1.Common stock offered by the company 7,645,259 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 46,976,277 shares of common stock outstanding as of September 30, 2020.
from June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of options
from March 31, 2020 to June 30, 2020
Issuance of common stock upon exercise of options
Issuance of common stock upon initial public offering, net
Automatic conversion of preferred stock
Issuance of common stock upon conversion of debt
Issuance of common stock upon vesting of restricted stock unit awards
Issuance of Series B Preferred Stock, net
1.Common stock offered by us 6,666,667 shares.